Skip to main content
Log in

Concentration of serum bile acids as an index of hepatic damage in systemic lupus erythematosus

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

The aim of this work is to evaluate the concentration of serum bile acids (SBA) as an index of impaired liver function in systemic lupus erythematosus (SLE) patients versus usual laboratory tests of hepato-biliary system diseases. In patients with SLE the mean fasting SBA concentration was 9.6±1.4μmol/L; in normal subjects the concentration was 2.9±0.6μmol/L (P<0.01). In patients with SLE, mean gamma-glutamyl transpeptidase (GGTP) concentration was 31.5 ±5.9 mU/ml versus 10.05±1.1 mU/ml in controls (P<0.01).The bromsulphalein (BSP) excretion test, 45 minutes after injection, was 6.8±1% in SLE patients versus 2.8±0.4% in controls (P<0.02). No significant difference was found between these two groups of subjects with respect to leucine aminopeptidase (LAP), alkaline phosphatase (AlPh), glutamic-oxalacetic transaminase (SGOT), glutamicpyruvic transaminase (SGPT), bilirubin serum rates. SBA rate was abnormal in 50% of the SLE patients; GGTP rate and the BSP excretion test were abnormal in 38% and 27% respectively. Our findings show the presence of an actual liver impairment in SLE patients, significantly demonstrated by fasting SBA concentration, GGTP rate and BSP excretion test. Other liver function tests are less useful in evaluating hepatic damage in SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Altomonte, L., et al. Gli acidi biliari sierici nella cirrosi epatica. Min Med 1980, 71, 2483.

    CAS  Google Scholar 

  2. Altomonte, L. et al. Le concentrazioni degli acidi biliari sierici come indice di danno epatico nella artrite reumatoide. Min Med 1982, 73, 1695.

    CAS  Google Scholar 

  3. Appelbaum, J.J., Job, N., Kern, F. Hepatitis associated with disseminated lupus erythematosus Gastroenterology 1961, 40, 766.

    PubMed  CAS  Google Scholar 

  4. Aronson, A.R., Montgomery, M.M. Chronic liver disease with a “lupus erythematosus-like syndrome”. Arch Intern Med 1959, 104, 544.

    PubMed  CAS  Google Scholar 

  5. Bouchier, I.A.D., Pennington, C.R. Serum bile acids in hepatobiliary disease Gut, 1978, 19, 492.

    PubMed  CAS  Google Scholar 

  6. Cohen, A.S., Canoso, J.J. Criteria for the classification of systemic lupus erythematosus status. Arthritis Rheum 1972, 15, 540.

    PubMed  CAS  Google Scholar 

  7. Dubois, E.I., Tuffonelli, D.L. Clinical manifestations of systemic lupus erythematosus. JAMA, 1964, 190, 112.

    PubMed  Google Scholar 

  8. Fausa, O., Gjone, E. Serum bile acids concentration in patients with liver disease. Scand J Gastroenterol 1976, 11, 229.

    PubMed  CAS  Google Scholar 

  9. Fraisse, M. et al. The liver in the course of lupus erythematosus disseminatus. J Med Lyon, 1970, 51, 1067.

    PubMed  CAS  Google Scholar 

  10. Froelich, A.L., Van De Putte, I. Chronic hepatitis in lupus erythematosus disseminatus. Acta Gastroenterol Belg, 1966, 29, 683.

    PubMed  Google Scholar 

  11. Hannes, G.A., Stellaard, F., Paumgartner, G. Increased serum bile acids in cirrhosis with normal transaminases. Digestion, 1982, 25, 217.

    Article  PubMed  Google Scholar 

  12. Harvey, A.M., et al. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore), 1954, 33, 291.

    CAS  Google Scholar 

  13. Hughes, G.R.V. Systemic lupus erythematosus In: Clinical Rhematology, Editors: Mason M. and Currey N.L.F., Philadelphia, J.B. Lippincott Co., 1970, 140.

    Google Scholar 

  14. Kofman, S., Johnson, G.L., Zimmerman, H.J. Apparent hepatic disfunction in lupus erythematosus. Arch Intern Med, 1955, 95, 669.

    CAS  Google Scholar 

  15. Makino, I., Nakagawa, S., Mashimo, K. Conjugated and unconjugated serum bile acids levels in patients with hepatobiliary diseases. Gastroenterology, 1969, 56, 1033.

    PubMed  CAS  Google Scholar 

  16. Rothfield, M.F. Systemic lupus erythematosus. In: Rheumatic diseases: diagnosis and management. Editor: Katz W., Philadelphia, J.B. Lippincott CO, 1977, 765.

    Google Scholar 

  17. Runyon, B.A; LaBreque, D.R., Anuras, S. The spectrum of liver disease in systemic lupus erythematosus. Am J Med, 1980, 69, 187.

    Article  PubMed  CAS  Google Scholar 

  18. Tamai, Y.S., Ito, K., Fukosi, M. Application of the preliminary SLE criteria by the ARA to immune hepatitis. Ryumachi, 1974, 14, 88.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Altomonte, L., Zoli, A., Sommella, L. et al. Concentration of serum bile acids as an index of hepatic damage in systemic lupus erythematosus. Clin Rheumatol 3, 209–212 (1984). https://doi.org/10.1007/BF02030756

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02030756

Key words

Navigation